The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.
23 September 2014
At this OHE Lunchtime Seminar, Dr Steven Pearson of ICER will discuss his "value framework," meant to guide drug and device assessment in the US.
18 August 2014
Prof Mills cautions that UHC will differ by country and be a process over time, not a fixed endpoint.
11 August 2014
This paper explores how the EQ-5D indexing process may obscure important information about health states.
05 August 2014
In this publication, leading experts in the field of health economics address today's critical issues in achieving value in health care.
17 July 2014
OHE's recent contributions in external forums are outlined in this blog post.
02 July 2014
This report explores the strength and nature of interdependencies in cancer research funding in the UK.